# A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis

> **NCT00509847** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **AM-Pharma**

## Conditions studied

- Staphylococcal Infections
- Bacteremia

## Interventions

- **DRUG:** human lactoferrin peptide 1-11

## Key facts

- **NCT ID:** NCT00509847
- **Lead sponsor:** AM-Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** conduct (recruitment) not feasible within timeframe
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509847, "A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00509847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*